| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
6e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-06 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |